patient_id_20186773.json

{
  "patient_id": "20186773",
  "tool_results": [
    {
      "tool_id": "402",
      "tool_name": "Intracerebral Hemorrhage (ICH) Score",
      "params": {
        "Glasgow Coma Score": "3-4",
        "Age >=80": "No",
        "ICH volume >=30mL": "Yes",
        "Intraventricular hemorrhage": "Yes",
        "Infratentorial origin of hemorrhage": "No"
      },
      "tool_summary": "ICH Score: [4, 97% mortality]"
    },
    {
      "tool_id": "715",
      "tool_name": "NIH Stroke Scale/Score (NIHSS)",
      "params": {
        "1A: Level of consciousness": "Postures or unresponsive",
        "1B: Ask month and age": "0 questions right ",
        "1C: 'Blink eyes' & 'squeeze hands'": "Performs 0 tasks",
        "2: Horizontal extraocular movements": "Forced gaze palsy: cannot be overcome",
        "3: Visual fields": "Complete hemianopia",
        "4: Facial palsy": "Unilateral complete paralysis (upper/lower face)",
        "5A: Left arm motor drift": "No movement",
        "5B: Right arm motor drift": "No movement",
        "6A: Left leg motor drift": "No movement",
        "6B: Right leg motor drift": "No movement",
        "7: Limb Ataxia": "No ataxia",
        "8: Sensation": "Complete loss: cannot sense being touched at all",
        "9: Language/aphasia": "Mute/global aphasia: no usable speech/auditory comprehension",
        "10: Dysarthria": "Normal",
        "11: Extinction/inattention": "Profound hemi-inattention (ex: does not recognize own hand)"
      },
      "tool_summary": "NIH Stroke Scale/Score (NIHSS): [37, severe stroke]"
    },
    {
      "tool_id": "3883",
      "tool_name": "Functional Outcome in Patients With Primary Intracerebral Hemorrhage (FUNC) Score",
      "params": {
        "ICH volume (cm³)": ">60",
        "Age": "<70",
        "ICH location": "Deep",
        "GCS score": "<=8",
        "Pre-ICH cognitive impairment": "No"
      },
      "tool_summary": "3883_FUNC Score: [4, extremely low probability of functional independence at 90 days]"
    },
    {
      "tool_id": "3802",
      "tool_name": "Secondary Intracerebral Hemorrhage (sICH) Score",
      "params": {
        "Probability of vascular cause on non-contrast computed tomography (NCCT)": "Indeterminate",
        "Age": ">71 years",
        "Sex": "Male",
        "Absence of both hypertension AND impaired coagulation": "No"
      },
      "tool_summary": "3802_sICH Score: [1, very low risk for vascular cause of ICH]"
    },
    {
      "tool_id": "1756",
      "tool_name": "Modified NIH Stroke Scale/Score (mNIHSS)",
      "params": {
        "1B: Level of consciousness/orientation questions": "0 questions correct",
        "1C: Level of consciousness commands": "0 tasks correct",
        "2: Test horizontal extra-ocular movements": "Total gaze palsy",
        "3: Test visual fields": "Bilateral hemianopia",
        "5A: Test left arm motor drift": "No movement",
        "5B: Test right arm motor drift": "No movement",
        "6A: Test left leg motor drift": "No movement",
        "6B: Test right leg motor drift": "No movement",
        "8: Test sensation": "Abnormal; sensory loss",
        "9: Test language/aphasia": "Mute/global aphasia",
        "11: Test extinction/inattention/neglect": "Severe"
      },
      "tool_summary": "Modified NIH Stroke Scale (mNIHSS): [31, severe stroke]"
    },
    {
      "tool_id": "1750",
      "tool_name": "Geneva Score (Revised) for Pulmonary Embolism",
      "params": {
        "Age >65": "No",
        "Previous DVT or PE": "No",
        "Surgery (under general anesthesia) or lower limb fracture in past month": "Yes",
        "Active malignant condition": "No",
        "Unilateral lower limb pain": "No",
        "Hemoptysis": "No",
        "Heart rate": "< 75",
        "Pain on lower limb palpation and unilateral edema": "No"
      },
      "tool_summary": "1750 Geneva Score (Revised): [2, low risk group: 7-9% incidence of PE]"
    },
    {
      "tool_id": "807",
      "tool_name": "HAS-BLED Score for Major Bleeding Risk",
      "params": {
        "Hypertension": "Yes",
        "Renal disease": "Yes",
        "Liver disease": "No",
        "Stroke history": "Yes",
        "Prior major bleeding or predisposition to bleeding": "Yes",
        "Labile INR": "No",
        "Age >65": "No",
        "Medication usage predisposing to bleeding": "Yes",
        "Alcohol use": "No"
      },
      "tool_summary": "HAS-BLED Score: [5, high risk of major bleeding]"
    },
    {
      "tool_id": "1785",
      "tool_name": "HEMORR₂HAGES Score for Major Bleeding Risk",
      "params": {
        "Hepatic or Renal Disease": "Yes",
        "Ethanol (Alcohol) Abuse": "No",
        "Malignancy History": "No",
        "Older (Age >75)": "No",
        "Reduced Platelet Count or Function": "No",
        "Rebleeding Risk": "Yes",
        "Hypertension (Uncontrolled)": "Yes",
        "Anemia": "No",
        "Genetic Factors": "No",
        "Excessive Fall Risk": "No",
        "Stroke History": "Yes"
      },
      "tool_summary": "HEMORR2HAGES Score: [5, 12.3% risk of bleeding per 100 patient-years]"
    },
    {
      "tool_id": "89",
      "tool_name": "Ranson's Criteria for Pancreatitis Mortality",
      "params": {
        "WBC >16k": "No",
        "Age >55 years": "Yes",
        "Glucose >200 mg/dL (>11.1 mmol/L)": "No",
        "AST >250": "No",
        "LDH >350": "No",
        "Hct drop >10% from admission": "No",
        "BUN increase >5 mg/dL (>1.79 mmol/L) from admission": "Yes",
        "Ca ": "No",
        "Arterial pO2 ": "No",
        "Base deficit (24 - HCO3) >4 mg/dL within 48 hours": "No",
        "Fluid needs >6 L within 48 hours": "No"
      },
      "tool_summary": "Ranson's Criteria on Admission: [1, unlikely severe pancreatitis]; Ranson's Criteria Cumulative: [2, 1% predicted mortality]"
    },
    {
      "tool_id": "10045",
      "tool_name": "Kidney Failure Risk Calculator",
      "params": {
        "eGFR, mL/min/1.73m²": "10-14",
        "Sex": "Male",
        "Urine albumin-to-creatinine ratio, mg/g": ">300",
        "Age, years": "60-69",
        "Serum albumin, g/dL (g/L)": "<=2.5 (<=25)",
        "Serum phosphorus, mg/dL (mmol/L)": ">5.5 (>1.78)",
        "Serum bicarbonate, mEq/L (mmol/L)": "<18 (<18)",
        "Serum calcium, mg/dL (mmol/L)": "8.6-9.5 (2.12-2.37)"
      },
      "tool_summary": "Kidney Failure Risk Calculator: [NaN, unable to assess risk]"
    },
    {
      "tool_id": "10092",
      "tool_name": "ACR/EULAR 2010 Rheumatoid Arthritis Classification Criteria",
      "params": {
        "Joint involvement": "1 large joint",
        "Serology (need at least one serology test result to use these criteria)": "Negative rheumatoid factor and negative anti-citrullinated protein antibody",
        "Acute-phase reactants (need at least one acute-phase reactant test result to use these criteria)": "Normal CRP and normal ESR",
        "Duration of symptoms": "<6 weeks"
      },
      "tool_summary": "ACR/EULAR Criteria for Rheumatoid Arthritis Result: [0 points, Unlikely RA]"
    },
    {
      "tool_id": "10038",
      "tool_name": "Braden Score for Pressure Ulcers",
      "params": {
        "Sensory perception": "Completely limited: unresponsive to painful stimuli due to diminished consciousness or sedation, OR limited ability to feel pain over most of body",
        "Moisture": "Very moist: skin is often but not always moist; linen must be changed at least once a shift",
        "Activity": "Bedfast: confined to bed",
        "Mobility": "Completely immobile: does not make even slight changes in body or extremity position without assistance ",
        "Nutrition": "Very poor: never eats complete meal; rarely eats >⅓ of any food offered; eats <=2 servings protein (meat or dairy) daily; takes fluids poorly; does not take liquid dietary supplement; or is NPO and/or maintained on clear liquids or IV for >5 days",
        "Friction and shear": "Problem: requires moderate to maximum assistance in moving; complete lifting without sliding against sheets is impossible; frequently slides down in bed or chair, requiring frequent repositioning with maximum assistance; spasticity, contractures, or agita"
      },
      "tool_summary": "Braden Score: [7, high risk]"
    },
    {
      "tool_id": "10477",
      "tool_name": "EUROMACS-RHF Score",
      "params": {
        "RA/PCWP >0.54": "No",
        "Hemoglobin <=10 g/dL": "Yes",
        "Multiple intravenous inotropes": "No",
        "INTERMACS class 1-3": "Yes",
        "Severe RV dysfunction": "No"
      },
      "tool_summary": "EUROMACS-RHF Score: [3, Intermediate risk of RHF]"
    },
    {
      "tool_id": "10088",
      "tool_name": "Cumulative Illness Rating Scale-Geriatric (CIRS-G)",
      "params": {
        "Heart": "CHF compensated with meds, daily antianginal meds, left ventricular hypertrophy, atrial fibrillation, bundle branch block, daily antiarrhythmic drugs ",
        "Vascular": "Daily antihypertensive meds, one symptom of atherosclerotic disease (angina, claudication, bruit, amaurosis fugax, absent pedal pulses), aortic aneurysm <4 cm",
        "Hematopoietic": "Hemoglobin: females 8 to <10 g/dL, males 10 to <12 g/dL, anemia secondary to iron/vitamin B-12/folate deficiency or chronic renal failure, total WBC 2,000-4,000",
        "Respiratory": "Limited ambulation secondary to limited respiratory capacity, requires oral steroids for lung disease, smoked >40 pack years",
        "Eyes, ears, nose, throat, and larynx": "No problem",
        "Upper GI  ": "No problem",
        "Lower GI": "No problem",
        "Liver, pancreas, and biliary ": "No problem",
        "Renal ": "Requires dialysis, renal carcinoma",
        "Genitourinary": "No problem",
        "Musculoskeletal and skin": "Daily antiarthritic meds or use of assistive devices or moderate limitation in ADLs, daily meds for chronic skin conditions, melanoma without metastasis",
        "Neurologic": "Status post CVA with residual functional hemiparesis or aphasia, severe neurodegenerative disease",
        "Endocrine and breast ": "Brittle or poorly controlled diabetes mellitus or diabetic coma in the past year, requires adrenal hormone replacement, adrenal, thyroid, or breast carcinoma",
        "Psychiatric illness": "No problem"
      },
      "tool_summary": "Mini/SOFA Score: [23, high severity]"
    },
    {
      "tool_id": "4044",
      "tool_name": "Simplified Acute Physiology Score (SAPS) II",
      "params": {
        "Age, years": "70-74",
        "Heart rate": "70-119",
        "Systolic BP, mmHg": "100-199",
        "Temperature >=39ºC (102.2ºF)": "No",
        "GCS": "<6",
        "PaO₂/FiO₂, if on mechanical ventilation or CPAP ": "100-199 mm Hg/% (13.3-26.5 kPa/%)",
        "BUN, mg/dL or serum urea, mmol/L": "BUN >=84 or urea >=30",
        "Urine output, mL/day": "<500",
        "Sodium, mEq/L or mmol/L": ">=145",
        "Potassium, mEq/L": "<3.0",
        "Bicarbonate, mEq/L": ">=20",
        "Bilirubin": "<4.0 mg/dL (<68.4 µmol/L)",
        "WBC, x 10³/mm³": "1.0-19.9",
        "Chronic disease": "None",
        "Type of admission": "Unscheduled surgical"
      },
      "tool_summary": "SAPS II Score: [83, 94.1% in-hospital mortality]"
    },
    {
      "tool_id": "10471",
      "tool_name": "Acute Renal Failure after Cardiac Surgery (Thakar Score)",
      "params": {
        "Gender": "Male",
        "Congestive heart failure": "No",
        "Left ventricular ejection fraction ": "No",
        "Preoperative use of IABP": "No",
        "COPD": "No",
        "Insulin-requiring diabetes": "No",
        "Previous cardiac surgery": "No",
        "Emergency surgery": "No",
        "Surgery type": "None",
        "Preoperative creatinine, mg/dL": ">2.0"
      },
      "tool_summary": "Thakar Score: [5 points, 1.8% risk of ARF]"
    },
    {
      "tool_id": "10007",
      "tool_name": "Embolic Stroke of Undetermined Source (ESUS) Criteria",
      "params": {
        "Non-lacunar ischemic stroke on CT or MRI": "No",
        "Absence of atherosclerosis (extra- or intracranial) causing >=50% luminal stenosis in arteries supplying the ischemic area": "Yes",
        "No major risk cardioembolic source": "Yes",
        "No other specific cause of stroke identified": "No"
      },
      "tool_summary": "ESUS Criteria Result: [Negative, low risk of embolic stroke]"
    },
    {
      "tool_id": "10430",
      "tool_name": "Modified Rankin Score-9Q (mRS-9Q)",
      "params": {
        "Q1: Do you have any symptoms that are bothering you?": "No",
        "Q2: Are you able to do the same work as before?": "No",
        "Q3: Are you able to keep up with your hobbies?": "No",
        "Q4: Have you maintained your ties to friends and family?": "No",
        "Q5: Do you need help making a simple meal, doing household chores, or balancing a checkbook?": "Yes",
        "Q6: Do you need help with shopping or traveling close to home?": "Yes",
        "Q7: Do you need another person to help you walk?": "Yes",
        "Q8: Do you need help with eating, going to the toilet, or bathing?": "Yes",
        "Q9: Do you stay in bed most of the day and need constant nursing care?": "Yes"
      },
      "tool_summary": "Medical Tool Output Analysis (ID: 10430): [Potential conflicts identified, high risk due to inconsistent reporting]"
    },
    {
      "tool_id": "3948",
      "tool_name": "EGSYS (Evaluation of Guidelines in SYncope Study) Score for Syncope",
      "params": {
        "Abnormal EKG and/or heart disease": "No",
        "Palpitations before syncope": "No",
        "Syncope during effort ": "No",
        "Syncope in supine position": "No",
        "Autonomic prodromes": "Yes",
        "Predisposing and/or precipitating factors": "Yes"
      },
      "tool_summary": "EGSYS Score: [-2, Cardiac syncope less likely; 3% mortality at 21-24 months for EGSYS <3]"
    },
    {
      "tool_id": "10578",
      "tool_name": "Genetically Inspired Prognostic Scoring System (GIPSS) for Primary Myelofibrosis (PMF)",
      "params": {
        "Karyotype classification": "Unfavorable2",
        "Type 1/like CALR mutation": "No",
        "ASXL1 mutation": "No",
        "SRSF2 mutation": "No",
        "U2AF1Q157 mutation": "No"
      },
      "tool_summary": "GIPSS for PMF: [2, Intermediate-2 risk, 5-year overall survival: 40%, Median overall survival: 4.2 years]"
    }
  ]
}